Last 34 quarters of trend data · Basic Materials · Agricultural Inputs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has compressed 10.6% YoY to 8.6x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.45 | — | — | — | — | 950.00 | — | — | 22.61 | 2019.12 | — | — | 6.45 |
| — | — | — | — | — | -52.9% | — | — | +250.5% | — | — | — | — | |
| P/S Ratio | 0.07 | 0.28 | 0.29 | 0.95 | 1.20 | 0.97 | 1.34 | 1.37 | 2.52 | 1.56 | 1.53 | 2.00 | 1.97 |
| — | -71.0% | -78.4% | -30.5% | -52.2% | -37.8% | -12.5% | -31.6% | +27.8% | -20.3% | -3.6% | +28.9% | -4.1% | |
| P/B Ratio | 0.08 | 0.78 | 0.32 | 0.96 | 0.83 | 1.11 | 1.43 | 1.94 | 2.43 | 2.62 | 2.19 | 2.54 | 2.19 |
| — | -29.7% | -77.6% | -50.8% | -65.7% | -57.6% | -34.8% | -23.4% | +10.8% | +4.9% | -16.6% | -36.1% | -54.2% | |
| P/FCF | 0.67 | 1.46 | 2.27 | 2.87 | 3.56 | — | 61.34 | 9.87 | — | 25.09 | 20.30 | — | — |
| — | — | -96.3% | -70.9% | — | — | +202.1% | — | — | +389.8% | — | — | — | |
| EV / EBITDA | 19.54 | 8.64 | 6.28 | — | 18.62 | 9.67 | 20.32 | 14.07 | 14.94 | 12.54 | 22.98 | 27.53 | 6.73 |
| — | -10.6% | -69.1% | — | +24.6% | -22.9% | -11.6% | -48.9% | +122.0% | -59.6% | +96.2% | +94.3% | -84.2% | |
| EV / EBIT | — | 13.77 | 26.82 | — | 233.29 | 12.73 | — | 91.77 | 17.89 | 18.40 | 48.63 | 180.02 | 7.96 |
| — | +8.2% | — | — | +1203.7% | -30.8% | — | -49.0% | +124.9% | — | +182.4% | +629.4% | -87.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Bioceres Crop Solutions Corp.'s operating margin was 10.6% in Q2 2026, up 0.6 pp QoQ and down 4.7 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 0.5% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 14.5% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.1% | 35.7% | 46.0% | 32.5% | 39.4% | 41.8% | 40.2% | 33.5% | 50.7% | 36.7% | 37.5% | 36.8% | 60.6% |
| — | -14.5% | +14.5% | -2.8% | -22.3% | +13.9% | +7.3% | -9.1% | -16.3% | +2.8% | -7.6% | +2.7% | +74.8% | |
| Operating Margin | -1.1% | 10.6% | 10.0% | -20.0% | 1.6% | 15.4% | 4.0% | 7.6% | 15.7% | 12.0% | 4.6% | 4.9% | 32.1% |
| — | -30.9% | +153.4% | -362.5% | -90.0% | +28.3% | -13.2% | +57.0% | -51.1% | +410.2% | -66.0% | -50.6% | +920.6% | |
| Net Margin | -15.5% | -248.4% | -9.5% | -59.5% | -2.2% | 0.1% | -6.9% | -1.2% | 11.0% | 0.1% | -4.0% | -1.6% | 30.3% |
| — | -171204.5% | -37.6% | -4735.8% | -119.9% | +87.8% | -74.0% | +24.2% | -63.7% | +100.9% | -1106.1% | +67.1% | +419.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.0% | -94.9% | -2.6% | -13.8% | -0.4% | 0.0% | -1.8% | -0.4% | 2.7% | 0.0% | -1.4% | -0.5% | 8.9% |
| — | -228829.9% | -39.3% | -3054.7% | -113.9% | +26.1% | -30.4% | +14.6% | -69.7% | +101.2% | -753.6% | +85.9% | +257.3% | |
| ROA | -6.4% | -28.3% | -1.0% | -5.7% | -0.2% | 0.0% | -0.8% | -0.2% | 1.1% | 0.0% | -0.6% | -0.2% | 3.3% |
| — | -163472.8% | -28.8% | -3025.5% | -114.3% | +30.1% | -35.4% | +11.5% | -65.9% | +101.4% | -832.9% | +79.1% | +346.0% | |
| ROIC | -0.5% | 1.4% | 1.1% | -2.0% | 0.1% | 1.9% | 0.5% | 1.2% | 1.7% | 2.3% | 0.7% | 0.7% | 4.3% |
| — | -29.7% | +128.8% | -263.3% | -93.2% | -16.6% | -35.1% | +72.5% | -59.1% | +607.3% | -76.9% | -72.6% | +626.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Bioceres Crop Solutions Corp.'s Debt/EBITDA ratio is 26.6x, up from 19.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 32.4% YoY to 0.90x, tightening the short-term liquidity position. Debt/Equity has risen for 4 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.94 | 2.25 | 0.96 | 0.94 | 0.79 | 0.82 | 0.77 | 0.78 | 0.73 | 0.71 | 0.77 | 0.78 | 0.79 |
| — | +172.3% | +24.5% | +20.8% | +8.2% | +16.8% | -0.0% | -0.4% | -7.3% | -25.1% | -6.7% | -27.4% | -55.2% | |
| Debt / EBITDA | 20.20 | 26.58 | 19.70 | — | 39.00 | 17.24 | 29.71 | 16.84 | 14.06 | 10.90 | 24.62 | 27.04 | 7.57 |
| — | +54.2% | -33.7% | — | +177.4% | +58.2% | +20.6% | -37.7% | +85.7% | -70.2% | +110.0% | +115.0% | -84.3% | |
| Current Ratio | 0.91 | 0.90 | 0.94 | 0.91 | 1.02 | 1.32 | 1.27 | 1.24 | 1.22 | 1.24 | 1.27 | 1.33 | 1.39 |
| — | -32.4% | -25.9% | -26.4% | -16.8% | +7.1% | +0.5% | -6.7% | -12.1% | -9.4% | -15.0% | -0.6% | +19.5% | |
| Quick Ratio | 0.65 | 0.69 | 0.65 | 0.65 | 0.74 | 0.96 | 0.87 | 0.86 | 0.83 | 0.84 | 0.81 | 0.86 | 0.89 |
| — | -27.8% | -26.0% | -24.6% | -11.2% | +13.4% | +8.2% | -0.2% | -6.4% | -2.2% | -8.1% | +11.4% | +31.1% | |
| Interest Coverage | -0.08 | 0.81 | 0.37 | -0.57 | 0.09 | 2.38 | -0.23 | 0.34 | 3.44 | 2.03 | 0.68 | 0.25 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 34 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BIOX stock.
Bioceres Crop Solutions Corp.'s current P/E is -0.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Bioceres Crop Solutions Corp.'s current operating margin is -1.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Bioceres Crop Solutions Corp.'s business trajectory between earnings reports.